IQOS is the latest tobacco product to come on the market. But is IQOS any safer than e-cigarettes? Is it safer than regular cigarettes? Tobacco addiction expert Maher Karam-Hage, M.D., weighs in.

What happens when cancer recurs? Radiation oncologist and inflammatory breast cancer specialist Wendy Woodward, M.D., Ph.D., explains and shares four questions to ask your care team.

After a non-Hodgkin lymphoma recurrence, Ian Leybas joined a clinical trial at MD Anderson. Now in complete remission, Ian shares why he’s grateful for the clinical trial and encourages other cancer patients to consider clinical trials during treatment.

You want the most effective treatment for your breast cancer. Learn how molecular diagnostics can guide your doctors toward a treatment that works best for your tumor.

How is 5-fluorouracil/5-FU administered, and what are its side effects? Clinical pharmacist Stacy Diao answers these and three other questions about this common chemotherapy drug.

What’s the healthiest type of bean to eat? Why is it better to eat beans with rice? And how can you work more beans into your diet? Senior clinical dietitian Starla Garcia weighs in.

After being diagnosed with stage III invasive lobular carcinoma. Marcela de Leon Espinoza came to MD Anderson for her breast cancer treatment. Find out why she made that decision and joined a clinical trial here — even though she lives more than 300 miles away.

The internet is full of testimonials from people claiming IV vitamin therapy has helped them feel better, or that it can ease cancer treatment side effects. But is there any truth to these claims? And, is IV vitamin therapy safe? Our Meroë Morse, M.D., answers these and other questions.

Learning that one of our surgeons had performed thousands of the same procedure he was recommending for Tod Hornby’s prostate cancer treatment made choosing MD Anderson easy. But learning other things about MD Anderson has continued to astonish the Idaho resident.

Which activities burn the most calories? What’s the best way to measure calorie burn? Researcher Karen Basen-Engquist, Ph.D., answers.

What's the best way to support someone who’s facing cancer? Here are three highlights from a podcast discussion between social work counselor Cindy Parker and Program Manager Lauren Adams.

Can the damaging effects of smoking ever be reversed by exercise or a healthy diet? Tobacco addiction expert Maher Karam-Hage, M.D., weighs in on the “healthy smoker” myth.

Esthesioneuroblastoma is a rare cancer that forms in the nasal cavity. Ehab Hanna, M.D., shares esthesioneuroblastoma symptoms, treatment options and what to expect after treatment.

A mammogram is an important step in breast cancer screening that helps detect the disease as early as possible. Here’s what to expect at your first mammogram.

Find out why Susan Bullman is on this year’s list

Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body radiation therapy (SBRT) and surgery achieved similar survival outcomes at 10-year follow-up for patients with early-stage non-small cell lung cancer, with radiation offering quality-of-life benefits.

If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson's appointment process, our information page may be the best place to start.

Recent advances in radiation oncology have led to shorter treatment times, increased early disease detection, and artificial intelligence applications that continue to improve cancer care. Ahead of this week's 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, researchers from The University of Texas MD Anderson Cancer Center shared updates on expected key trends.

At the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, MD Anderson investigators will share new research that may shape the future of radiation oncology. Highlights include long-term data supporting non-surgical treatment options, advances in personalized pain relief and imaging innovations that could make care more precise.

After completing his radiation oncology residency at MD Anderson and joining the faculty, Vincent Bernard-Pagan, M.D., Ph.D., shares what he learned from his training and what sets MD Anderson apart for trainees.